Bluerock Therapeutics
Clinical trials sponsored by Bluerock Therapeutics, explained in plain language.
-
Stem cell injection trial aims to restore vision in the blind
Disease control Recruiting nowThis study is testing a new treatment called OpCT-001 for adults with inherited eye diseases that cause blindness, such as retinitis pigmentosa. The treatment involves injecting lab-grown light-sensitive eye cells into the back of the eye. The main goals are to see if the treatme…
Phase: PHASE1, PHASE2 • Sponsor: BlueRock Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC
-
Brain cell transplant trial offers new hope for Parkinson's patients
Disease control Recruiting nowThis study is testing whether transplanting specially grown brain cells into people with Parkinson's disease can improve their movement and reduce symptoms. About 102 participants will be randomly assigned to receive either the cell transplant or a sham surgery for comparison, an…
Phase: PHASE3 • Sponsor: BlueRock Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC